Eric M. Horwitz, MD, Named Chairman of the Department of Radiation Oncology at Fox Chase Cancer Center
PHILADELPHIA (November 6, 2009) – Radiation Oncologist Eric M. Horwitz, MD - Chair, Radiation Oncology; Gerald E. Hanks Chair in Radiation Oncology, has been named chairman of the department of radiation oncology at Fox Chase Cancer Center. Recognized nationally for his expertise in treating patients with prostate cancer, Horwitz will also hold the Gerald E. Hanks Endowed Chair in Radiation Oncology.
“Dr. Horwitz has distinguished himself as an expert in the management of localized prostate cancer, the delivery of brachytherapy, and as a productive clinical researcher and an outstanding physician,” says Michael V. Seiden, MD, PhD, president and CEO of Fox Chase. “He has shown to be a very capable administrative leader, having overseen the opening of the radiation facilities in the Young Pavilion and the launch of the Buckingham radiation therapy facility.”
Since joining the staff in 1997, Horwitz has developed advanced programs using intensity-modulated radiation therapy (IMRT), image-guided radiation therapy and brachytherapy. These include high-dose-rate (HDR) brachytherapy for prostate cancer, a treatment using temporary radiation implants. As a result, Fox Chase was the first institution in the Northeast United States to offer HDR implants to men with prostate cancer.
In addition, Horwitz integrated the use of an MRI treatment simulator into prostate cancer treatment planning for permanent, low-dose rate prostate implants and IMRT. Fox Chase was the first in the world to use MRI in radiation treatment planning.
Currently, national President of the American Brachytherapy Society, Horwitz has been ranked among Philadelphia Magazine's "Top Docs" in radiation. He has published extensively and has authored or co-authored more than 150 peer reviewed journal articles and chapters and serves on the editorial board of the journal Brachytherapy. He is also active in the American Society of Radiation Oncology and the American College of Radiology.
Horwitz received his MD from Albany Medical College in New York after earning his undergraduate degree at the University of Pennsylvania in Philadelphia. He completed both his internship and residency at William Beaumont Hospital in Royal Oak, Mich. He was chief resident in radiation oncology there before he came to Fox Chase in 1997.
Fox Chase Cancer Center, part of the Temple University Health System, is one of the leading cancer research and treatment centers in the United States. Founded in 1904 in Philadelphia as one of the nation’s first cancer hospitals, Fox Chase was also among the first institutions to be designated a National Cancer Institute Comprehensive Cancer Center in 1974. Fox Chase researchers have won the highest awards in their fields, including two Nobel Prizes. Fox Chase physicians are also routinely recognized in national rankings, and the Center’s nursing program has received the Magnet recognition for excellence four consecutive times. Today, Fox Chase conducts a broad array of nationally competitive basic, translational, and clinical research, with special programs in cancer prevention, detection, survivorship, and community outreach. For more information, call 1-888-FOX CHASE or (1-888-369-2427).
Media inquiries only, please contact Jeremy6 Moore at 215-728-2700.